In Monday's regular trading session, as of 1.00 pm, the following are the healthcare stocks that reached their 52 week high and 52 week low prices.
The 52-week high list
Affymax Inc. (AFFY) touched a new high of $17.88 today, and is currently trading at $17.74. The stock is up an impressive 169% year-to-date.
Air medical transporter Air Methods Corp. (AIRM) hit a new high of $118.50, and is currently trading at $117.18. The stock is up more than 38% year-to-date. Earlier this month, the company reported solid Q2 results and said it is optimistic for continued strength in the operating results for the second half of 2012.
Bio-Reference Laboratories Inc. (BRLI), a clinical testing laboratory, hit a new high of $30.09, and is currently trading at $29.90. The stock is up more than 83% year-to-date.
Health insurer Coventry Health Care Inc. (CVH) touched a new high of $41.70, and is currently trading at $41.56. The company has agreed to be acquired by rival Aetna (AET) for $7.3 billion, including the assumption of Coventry debt. The acquisition is expected to close in mid-2013. The stock is up nearly 37% year-to-date.
GenMark Diagnostics Inc. (GNMK), a molecular diagnostics company, hit a new high of $7.69, and is currently trading at $7.53. The stock is up 83% year-to-date.
Hanger Inc. (HGR), a medical device company, recorded a new high of $27.47, and is currently trading at $27.44. The stock is up more than 46% year-to-date. Earlier in the month, the company reported Q2 EPS growth of 11.1% on 7.2% increase in net sales.
Maxygen Inc. (MAXY), a biotechnology company, touched a new high of $6.24, and is currently trading at $6.10. The stock is up 8% year-to-date. The company's Board of Directors has authorized a special pro rata distribution of $3.60 per share for each outstanding share of Maxygen common stock owned on the close of business on the August 21, 2012 record date. The cash distribution is expected to be paid on September 6, 2012.
Medtronic Inc. (MDT), a medical technology company, set a new high of $41.29, and is currently trading at $41.22. The stock is up over 7% year-to-date. The company is scheduled to report its Q1, fiscal 2013, results on August 21. Analysts polled by Thomson Reuters expect the company to earn 85 cents per share on revenues of $4.00 billion during the quarter.
Patterson Companies Inc. (PDCO), a distributor of dental, veterinarian and rehabilitation medical supplies, touched a new high of $36.38, and is currently trading at $36.13. The stock is up more than 22% year-to-date. The company is scheduled to report its Q1, fiscal 2013, results on August 23. The analysts' estimates for Q1 are EPS of 49 cents per share and revenue of $883.53 million.
ResMed Inc. (RMD), a maker of sleep-aid devices, recorded a new high of $37.19, and is currently trading at $36.90. The stock is up 45% year-to-date. Earlier in the month, the company reported Q4 results - with earnings and revenue comfortably beating analysts' estimates.
Repros Therapeutics Inc. (RPRX) touched a new high of $11.19, and is currently trading at $11.16. The stock is up more than 131% year-to-date. Spectranetics Corp. (SPNC), a medical device manufacturer, set a new high of $12.59, and is currently trading at $12.49. The stock is up nearly 73% year-to-date.
SurModics Inc (SRDX), a provider of drug delivery and surface modification technologies to the healthcare industry, hit a new high of $18.69, and is currently trading at $18.59. The stock is up over 26% year-to-date. Earlier in the month, the company reported solid Q3, fiscal 2012 results, and provided upbeat outlook for the full year. SurModics commenced a tender offer to purchase up to $55 million of its common stock, at a price per share not less than $17.00 and not greater than $19.00, on August 6. The tender offer is slated to expire on September 5, 2012, unless it is extended.
Sunrise Senior Living Inc. (SRZ), a provider of senior living services, recorded a new high of $9, and is currently trading at $8.94. The stock is up nearly 38% year-to-date.
The 52-week Low List
Aastrom Biosciences Inc. (ASTM), a development stage company, fell to a new low of $1.56, and is currently trading at $1.65. The stock has lost 9% year-to-date.
InterMune Inc. (ITMN), a biotechnology company, slumped to a new low of $7.33, and is currently trading at $7.35. So far this year, the stock has lost nearly 42%.
Medical device company Nxstage Medical Inc. (NXTM) recorded a new low of $12.63, and is currently trading at $12.83. The stock has lost nearly 28% of its value year-to-date. Earlier this month, the company reported a narrower loss on 10% revenue growth in Q2. However, the Q3 outlook provided is below analysts' estimates.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.